Cargando…
Landscape of NcRNAs involved in drug resistance of breast cancer
Breast cancer (BC) leads to the most amounts of deaths among women. Chemo-, endocrine-, and targeted therapies are the mainstay drug treatments for BC in the clinic. However, drug resistance is a major obstacle for BC patients, and it leads to poor prognosis. Accumulating evidences suggested that no...
Autor principal: | Kang, Yujuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250522/ https://www.ncbi.nlm.nih.gov/pubmed/37067729 http://dx.doi.org/10.1007/s12094-023-03189-3 |
Ejemplares similares
-
NcRNAs and Cholangiocarcinoma
por: Wangyang, Zheng, et al.
Publicado: (2018) -
Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance
por: He, Xiao, et al.
Publicado: (2021) -
Hypoxia-driven ncRNAs in breast cancer
por: H. Al-Zuaini, Hashim, et al.
Publicado: (2023) -
Regulation of ncRNAs involved with ferroptosis in various cancers
por: Hu, Chenxi, et al.
Publicado: (2023) -
Epigenetic Factors and ncRNAs in Testicular Cancer
por: Nuñez-Corona, David, et al.
Publicado: (2023)